PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Elite Skills Arena (ESA) provide a range of training aids to improve performance. All ESA products are based around repetition, maximising training intensity for a more pronounced improvement.
days to go:
Expired
investment:
£72,603
Mogees is a London-based company with the objective to disrupt the relationship between people and physical objects. Their patent-pending technology allows anyone to transform ordinary physical objects into ‘smart’ ones through the power of machine learning and a vibration sensor.
days to go:
Expired
investment:
£1,153,867
Docandu is an innovative digital health platform designed both for patients & doctors, making digital healthcare accessible from anywhere. Docandu aims to be a key tech health service provider, starting from Greece, improving the existing national and private health care services. The global digital health market is estimated to be worth $536 Billion by 2025. To date, they have developed two separate apps for doctors and patients. They have also received an angel investment of 100,000 Euros and sponsorship of $25,000 from Microsoft. The company has initiated early-stage relationships with a couple of Greek public and private health entities. With the proceeds, they will execute their go-to-market strategy and make global health ID a reality, by expanding its affiliate network of doctors, health providers and public health systems.
days to go:
Expired
investment:
£70,900
Amino focuses on targeted nutrition using amino acids to improve human health, emphasizing the untapped potential beyond sports and bodybuilding. Currently offering pre- and intra-workout amino acid drinks, the company aims to expand its product line to cater to a broader consumer base, believing the market lacks variety in ready-to-mix powdered blends. Backed by scientific research and a commitment to taste and accessibility, Amino aspires to emerge as the leading global brand in amino acid products.
days to go:
Expired
investment:
£193,219
Supponor have designed Virtual Replacement Technology that is set to revolutionise the sports sponsorship advertising at events around the world. Their technology enables TV and digital broadcasters to display specific, relevant messaging in local languages for brands to target specific fans
(EIS Pending)
days to go:
Expired
investment:
£872,120
Fnatic is a global esports performance brand headquartered in London, focused on seeking out, levelling up and amplifying gamers and creators. It asserts that it is the most successful esports brand of the last decade, winning more than 200 championships across 30 different games. It has also won prize money worth $15 million and has been broadcast to a global audience of 55 million. Fnatic has delivered content and activations for brands like BMW, Gucci, AMD, Hi-Sense and Monster. The company also makes performance equipment that it sells directly and via global retailers to consumers. Fnatic will use the investment to improve its performance team, products, academies and facilities.
days to go:
Expired
investment:
£2,071,785
Offering coached performance training through an immersive class experience in a premium boutique gym environment. Binary Fitness are in the process of building a multi-purpose training hall and two spaces for classes that will deliver CrossFit courses, as well as yoga and strength sessions.
Binary Fitness currently has 200 members that pay a monthly membership averaging £160 and has YoY net membership growth of 34% up to September 2018. In the past 3 months, the company has achieved sales averaging £30k per month. Revenue is generated via tiered membership subscriptions, personal training, a café and brand merchandise.
days to go:
Expired
investment:
£707,630
